It has been proven that the main factor in the uncertainty of laboratory results is biological variation, that is, a change in the composition of human biomaterials, reflecting the course of life processes in the body and is characterized by a combination of the constancy of the internal environment and dynamic fluctuations around the homeostasis point. The paper offers objectively substantiated recommendations for the accuracy of laboratory tests, established maximum allowable values of analytical errors of quantitative research methods (measurements) of physical quantities (composition and properties of components of biological materials, analytes) in samples of biological materials. The interpretation of LOD and LOQ for detecting the concentration of leaching micro-impurities in the bioliquid. The identified patterns indicate that the elements of microimpurities have different dissolution rates. The ratio of hydroxyapatite/tricalcium phosphate affects the dissolution rate of the material: the higher the content of β-tricalcium phosphate, the higher the dissolution rate. The results of the research allow establishing recommendations for reducing inaccuracies in determining the composition of bone substitutes based on hydroxyapatite/β-tricalcium phosphate, which is associated with manifestations of biological variation, reflecting the body’s response to various environmental factors and subject to statistical laws.
[1] V. Gubala, L. Johnston, H. Krug, C. Moore, C. Ober, V. Schwenk "Engineered nanomaterials and human health", Part 2, Pure Appl. Chem. 90, pp.1325 - 1356, 2018.
https://doi.org/10.1515/pac-2017-0102
[2] J. Y. Park, S. H. Park, M. G. Kim, S. H. Park, T. H. Yoo, M. S. Kim, "Biomimetic Scaffolds for Bone Tissue Engineering", Advances in Experimental Medicine and Biology, no.1064, pp.109 - 121, 2018.
https://doi.org/10.1007/978-981-13-0445-3_7
[3] Neacsu, Serban, Nicoara, Roxana Trusca, Ene, Iordache, "Biomimetic Composite Scaffold Based on Naturally Derived Biomaterials", Polymers, no. 12, 2020.
https://doi.org/10.3390/polym12051161
[4] T. Miclaus, V. Valla, A. Koukoura, A. Nielsen, B. Dahlerup, Georgios-Ioannis Tsianos, E.Vassiliadis, "Impact of Design on Medical Device Safety", Therapeutic Innovation & Regulatory Science, pp. 54 839 - 849, 2020.
[5] S. Jahan, I. B. Yusoff, Y. B. Alias, "Reviews of the toxicity behavior of five potential engineered nanomaterials (ENMs) into the aquatic ecosystem", Toxicol Rep, no. 4, pp. 211 - 220, 2017.
https://doi.org/10.1007/s43441-019-00022-4
[6] J. C. L. Schuh, K. A. Funk, "Compilation of International Standards and Regulatory Guidance Documents for Evaluation of Biomaterials, Medical Devices, and 3-D Printed and Regenerative Medicine Products", Toxicologic Pathology, vol. 47, no. 3, pp. 344- 357, 2019.
https://doi.org/10.1177/0192623318804121
[7] ISO 14971:2019 Medical devices - Application of risk management to medical devices, 2019.
[8] ISO 13022:2012 Medical products containing viable human cells - Application of risk management and requirements for processing practices, 2012.
[9] ISO 10993-1:2018 Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process, 2018.
[10] ISO 10993-6:2016 Biological evaluation of medical devices - Part 6: Tests for local effects after implantation, 2016.
[11] ISO 10993-9:2019 Biological evaluation of medical devices - Part 9: Framework for identification and quantification of potential degradation products, 2019.
[12] ISO 10993-12:2012 Biological evaluation of medical devices - Part 12: Sample preparation and reference materials, 2012.
[13] ISO/CD 10993-17.2 Biological evaluation of medical devices - Part 17: Toxicological risk assessment of medical device constituents.
[14] ISO 10993-18:2020 Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process, 2020.
[15] ISO/TS 37137-1 Biological evaluation of absorbable medical devices - Part 1: General requirements. Biological evaluation of absorbable medical devices - Part 2: Standard guide for absorbable metals.
[16] ISO 14155:2020 Clinical investigation of medical devices for human subjects - Good clinical practice, 2020.
[17] A. Panda, J. Valicek, M. Harnicarova, M. Kusnerova, Z. Palkova, "Use of sorption of copper cations by clinoptilolite for wastewater treatment", International Journal of Environmental Research and Public Health, MDPI 15, no.7, pp.1-12, 2018.
https://doi.org/10.3390/ijerph15071364